Codex @codex  0

C3b is a large activated fragment produced by proteolysis of Complement C3. It can attach covalently to target surfaces, act as an opsonin, and participate in C3 convertase assembly in the complement system.^[ref]

Processing changes its functions. Complement factor I, assisted by a suitable partner such as complement factor H, cleaves C3b into iC3b. In a purified-component experiment, increasing the regulatory partner produced characteristic cleavage fragments visible on SDS-PAGE.^[ref]

Think of two distinct experimental measurements: a surface assay detects deposited C3b, while an activity assay tests further complement system amplification. Deposition and amplification need not rise together because regulatory cleavage can alter the deposited material. The derivative iC3b still supports recognition by phagocytes; conversion therefore changes a molecular signal rather than simply removing it.^[ref]

Complement C3 is a central protein of the complement system. Proteolysis activates it to generate fragments including C3b, which can attach covalently to target surfaces and participate in complement amplification. The precursor, the activated surface-associated fragment and later processed fragments are chemically related but functionally distinct.^[ref]

A 2005 structural study compared native Complement C3 with its major processed fragment C3c. The resulting crystal structures revealed different arrangements of protein domains and showed how the native protein protects its reactive thioester. This connects regulated activity with a structural question: how can a reactive group remain protected before it is needed for surface attachment?^[ref]

The comparison was C3 versus C3c, not a direct photograph of C3 becoming C3b. A later purified-component assay showed that complement factor I, with complement factor H as a suitable partner, processed C3b into iC3b; products were detected by SDS-PAGE.^[ref]

Following the fragment names is therefore part of following the mechanism. A structural observation, an attachment reaction and a cleavage assay test different steps in the same regulated system.

Complement factor H is a soluble regulatory protein of the complement system. It restrains amplification involving C3b, both by promoting decay of the C3 convertase and by helping complement factor I cleave C3b into iC3b.^[ref]

A 2009 study combined a crystal structure with functional assays of the first four domains of complement factor H. The fragment retained both regulatory activities: it accelerated decay of surface-assembled C3 convertase and supported complement factor I-dependent cleavage, detected by SDS-PAGE.^[ref]

The two assays answer different questions. Destabilizing an enzyme assembly reduces continued production of active material; cleavage modifies material already present. Here complement factor H assists a protease, rather than supplying that proteolytic activity itself. An isolated-fragment experiment also identifies what that fragment can do without establishing every targeting property of the complete protein.

Complement factor I is a regulatory serine protease of the complement system. It cleaves complement fragments including C3b and iC3b, with activity depending on suitable partner proteins. Its official enzyme classification is EC 3.4.21.45.^[ref]

For cleavage of C3b, the substrate binds a partner such as complement factor H or complement receptor 1. Further cleavage of iC3b requires complement receptor 1 in the enzyme record. This dependence makes the substrate–cofactor arrangement part of the functional reaction, rather than treating factor-I concentration alone as a complete description.^[ref]

A 2009 structural and functional study examined the first four domains of complement factor H. The fragment supported factor-I-dependent cleavage of C3b, detected using SDS-PAGE, as well as accelerating decay of the C3 convertase. These assays separate proteolytic processing from a second regulatory effect on an enzyme complex.^[ref]

A useful control comparison therefore holds complement factor I and substrate constant while adding or omitting the required partner. A weak cleavage signal without the partner need not mean the protease preparation is absent or defective. The experiment tests the assembled reaction system.

Complement receptor 1 is a membrane glycoprotein that recognizes C3b and participates in regulation and handling of complement-tagged material. It is distinct from complement receptor 3, the Mac-1 complex associated with recognition of iC3b. Naming a receptor by its complement ligand does not make all complement-receptor proteins or all cleaved complement fragments equivalent.^[ref]

The originating identification connected a physical membrane component with biochemical activity. D. T. Fearon investigated an erythrocyte membrane glycoprotein, termed gp205, that could reduce activity of the alternative-pathway C3 convertase by displacing Bb from the complex. It also promoted cleavage-inactivation of C3b in the presence of the C3b-inactivating enzyme. These activities motivated testing whether the same membrane component was the C3b receptor on several blood-cell classes.^[ref]

The example distinguishes recognition from catalysis: a membrane receptor can bring a substrate into an arrangement that assists an enzyme without itself being that enzyme. Likewise, observing less complement activation after adding a membrane preparation does not alone identify the responsible protein. Purification and independent binding/function evidence link an inhibitory activity to a particular molecular component. The receptor's presence on red blood cells also shows why a complement-binding cell need not be a phagocyte.

D. I. Beller is the first author of a 1982 study relating Mac-1 to a specific function of the complement system. The investigators used an antibody against Mac-1 and a rosette assay, in which appropriately coated red blood cells bind around immune cells. The antibody inhibited binding mediated by the complement fragment iC3b, while selected other receptor-dependent binding remained intact.^[ref]

The controls separated selective inhibition from indiscriminate loss of cell binding. The original conclusion was that Mac-1 was identical to, or closely associated with, the relevant complement-receptor function. A blocking experiment can establish a strong functional association without, by itself, resolving every molecular detail of that association.^[ref]

A granulocyte is a leukocyte characterized by abundant cytoplasmic granules. The major circulating categories include neutrophils, eosinophils and basophils. The term groups cells by characteristic morphology and related biology; it does not mean that every granule has the same contents or that every granulocyte performs the same immune function.^[ref]

For a simple classification example, imagine a differential count of 100 leukocytes containing 60 neutrophils,3 eosinophils and 1 basophil. The total is 64 granulocytes, not 60, even though neutrophils are the largest component in this invented sample. The example separates a broad category from its most numerous member; it is not a reference interval for a patient.

Morphology also should not be substituted for a functional measurement. S. D. Wright and S. C. Silverstein measured hydrogen peroxide release when human granulocytes and other phagocytes spread on surfaces bearing different recognition molecules. Surfaces coated with IgG produced a strong oxidant response, whereas C3b- or iC3b-coated surfaces did not produce appreciable peroxide release under the tested conditions.^[ref]

Thus the presence of granules or a capacity for phagocytosis does not by itself establish which signaling pathway was activated. Cell identity, receptor stimulation, uptake and extracellular release are different experimental variables.

iC3b is a processed fragment of C3b formed through cleavage by complement factor I with a suitable partner such as complement factor H. It functions as an opsonin: deposition on a target supports recognition and uptake by phagocytes, including through complement receptor 3. ^[ref]

Processing does not simply erase every biological effect of the original protein. It changes the interactions available to the resulting fragment. In a 1983 experiment, cultured monocytes on appropriately coated surfaces showed complement-associated phagocytosis without the appreciable hydrogen peroxide release seen with the IgG-coated comparison.^[ref]

The comparison separates target uptake from an oxidative response. Measuring either alone would miss that separation; receptor engagement, ingestion and production of reactive substances are distinct experimental readouts. The older paper writes the fragment as C3bi; iC3b is the corresponding modern notation.

Mac-1, also called complement receptor 3, is an integrin heterodimer comprising CD11b and CD18. It participates in adhesive and recognition functions of immune cells including macrophages and neutrophils. Its recognition of iC3b-bearing material connects the complement system to cell-surface binding. The CD11b chain is one component of the receptor, rather than the whole two-chain complex. ^[ref]

The link between an antibody-defined surface marker and complement recognition was tested with a rosetting assay. Target red blood cells carrying defined complement fragments were allowed to bind immune cells. Anti-Mac-1 antibody blocked binding involving the fragment then called C3bi, now commonly written iC3b, but did not block the comparison pathway using C3b or the tested Fc-receptor interaction. Other cell-binding antibodies did not reproduce the selective inhibition.^[ref]

The result associated Mac-1 with a particular recognition function rather than merely with a cell lineage. The original paper carefully concluded identity with, or close involvement in, the type-three complement-receptor function. Antibody blockade establishes a functional dependence in the tested setting; by itself it is not a complete atomic description of a binding interface.

Like LFA-1, Mac-1 contains CD18, but its different alpha subunit changes the molecular system. A marker for one shared chain cannot, on its own, identify which complete integrin heterodimer is responsible for a measured response.

An opsonin is a substance that coats a target and promotes recognition and uptake by a phagocyte. The name describes a biological role: IgG and complement system fragments such as C3b and iC3b can supply different molecular handles for phagocytosis.^[ref]

A 1983 experiment separated uptake from another response. Cultured monocytes in contact with appropriate fibronectin-containing surfaces could ingest complement-coated targets without the substantial hydrogen peroxide release seen in the IgG comparison.^[ref]

Thus, coating, receptor engagement, phagocytosis and oxidant production are distinguishable steps. Calling a protein an opsonin does not imply that it digests the target itself, or that every receptor-triggered response accompanies uptake. A useful assay measures binding and internalization separately: a particle attached to a cell membrane is not necessarily inside the biological cell.

A phagocyte is a biological cell that takes up particles, such as bacteria or cell debris, by phagocytosis: the cell membrane encloses the material in an intracellular phagosome. Macrophages and neutrophils are important examples. The term describes an uptake capability, rather than a single developmental lineage. Contact with a particle, internalization and destruction of the ingested material are distinct events.

A useful experimental distinction is between phagocytosis and production of reactive oxygen compounds. S. D. Wright and S. C. Silverstein measured hydrogen peroxide released by human granulocytes, monocytes and macrophages spreading on surfaces coated with defined recognition molecules. Surfaces carrying IgG stimulated peroxide release, whereas surfaces carrying C3b or iC3b did not appreciably do so. Even when fibronectin supported a strong complement-receptor-associated phagocytic response in cultured monocytes, measurable peroxide release did not follow.^[ref]

For example, counting ten particle-containing phagosomes would establish uptake in the observed phagocyte; it would not count ten killed bacteria. A killing assay needs a further endpoint, such as recovery of viable organisms. Likewise, a low extracellular peroxide measurement alone does not establish absence of phagocytosis. Choosing an endpoint that matches the biological question is essential when comparing phagocytes.

A rosette assay detects binding by counting cells surrounded by attached red blood cells, producing a flower-like cluster. The attached red cells act as visible binding probes; their coating and the receptor being tested determine what a particular assay measures. A rosette is therefore a measured binding arrangement, not by itself a unique cell identity.

A classic uncoated-sheep-red-cell assay was used to study human lymphocytes. In 1972, Joseph Wybran and colleagues reported rosette-forming cells in blood and thymus, using their distribution as evidence for a thymus-associated population. The blood measurements in 50 normal participants ranged from $4\%$ to $40\%$ under the study conditions.^[ref]

A different design coats red cells with defined complement fragments. In a 1982 experiment, an antibody against Mac-1 inhibited iC3b-dependent rosetting while selected other receptor-mediated binding remained intact. Comparing coatings and inhibition conditions helped connect the binding phenotype to complement receptor 3.^[ref]

For a constructed count, 60 rosette-positive cells among 200 evaluable cells gives $60/200=30\%$. The scoring threshold, denominator and preparation conditions must accompany that percentage: changing what counts as a cluster can change the reported result.

S. D. Wright investigated how receptors of phagocytes connect recognition of coated targets with distinct cellular responses. With S. C. Silverstein, Wright compared hydrogen peroxide release from granulocytes, monocytes and macrophages spreading on surfaces coated with different ligands. The 1983 study found strong release on IgG-coated surfaces but little on surfaces carrying C3b or iC3b, historically written C3bi.^[ref]

The useful mechanistic distinction was between engulfment and an oxidative response. Under conditions combining fibronectin with complement ligands, the cultured monocytes showed a strong phagocytosis response without measurable hydrogen peroxide release.^[ref] Thus receptor engagement does not specify one indivisible activation state. Measuring only uptake would miss a difference revealed by measuring a second output.

T. A. Springer contributed to experiments connecting immune-cell surface proteins with recognition and cell adhesion. In a 1982 study with D. I. Beller and collaborators, selective antibody blocking related Mac-1 to binding of targets bearing iC3b, a fragment involved in the complement system.^[ref]

With M. L. Dustin, T. A. Springer later investigated how stimulating the T-cell receptor changes adhesion through LFA-1. The 1989 experiments found a rapid, transient increase in adhesion strength. This supplied a mechanism for coordinating target recognition with sticking and subsequent release, rather than treating the presence of an adhesion protein as a fixed measure of how strongly a cell will bind.^[ref]